← back to ranking

HCA · HCA Healthcare, Inc.

Medical - Care Facilities · mkt cap $81.5B · calls: Q1 FY2026 vs Q4 FY2025
50.0 conviction · conf-adj 50

conf –

enthusiasm:24.0 · trend:0 · quantifies:0 · impact:0 · under_radar:14 · credibility:5 · business_impact:8 · disruption:0 · commitment:-4 · confirmation:3

Enthusiasm latest 8 / prev 9 (flat)

HCA’s AI thesis is credible but still mostly qualitative: management consistently links AI to physician documentation, nurse handoff, case management, revenue cycle, supply chain, staffing, throughput, and clinical decision support. Enthusiasm remains high, but the latest call shifts from broad strategic framing to implementation anecdotes without isolating dollar impact. Management discusses a $400 million resiliency program, but does not quantify the portion attributable to AI.

PAST (realized)
CURRENT (now)
FORWARD (guidance)
TRACK RECORD — PROMISE vs DELIVERY

50/100 track record   too-early  6 calls reviewed

HCA touts a 'digital transformation and AI agenda' and credits AI/automation as one of three levers behind its quantified ~$400M FY2026 resiliency savings target, but AI is never isolated as a standalone numbered deliverable and the one number tied to it is a FY2026 goal still in progress (reaffirmed, not yet proven). There is effectively no track record of judgeable delivered-or-missed quantified AI promises in this window.

~$400M of incremental resiliency cost savings in FY2026, with 'digital transformation with AI and automation' named as one of three primary capabilities driving the program — promised Q4 FY2025
too-early FY2026 still in progress; in Q1 FY2026 management reaffirmed the $400M resiliency assumption as 'reasonable and appropriate' but the full-year target cannot yet be judged
Resiliency program (incl. AI/automation + advanced analytics) to offset most of the $600M-$900M exchange/EPTC headwind in 2026 — promised Q4 FY2025
too-early Reaffirmed in Q1 FY2026; year not complete, offset not yet demonstrable
PRICED-IN (REFINED)
LOW (room left)

Est. revisions flat  ·  Fwd P/E 13.3  ·  EV/Sales 1.7x

AI claim maps to Managed Care And Other Insurers, Managed Medicare, Medicare

Analyst rating counts are essentially unchanged over recent months, and price-target data show only a slight last-quarter premium to the last-year average with no usable last-month signal, so estimate-revision momentum looks flat rather than rising. Forward EPS and revenue estimates grow steadily but not fast enough to suggest a major AI-driven reset is already in consensus. With a 13.3x forward P/E and 1.7x EV/Sales, valuation is not stretched for a mature healthcare facilities operator, so flat revisions plus reasonable valuation indicate AI upside is not yet heavily priced in.
COVERAGE — ENTHUSIASM TRAJECTORY + CATALYSTS
1Q4 FY20241Q1 FY20252Q2 FY20253Q3 FY20254Q4 FY20255Q1 FY2026

AI enthusiasm across 6 calls — trend ↗ rising

AI moved from absent to a named strategic agenda with facility rollouts, but management still offered limited concrete use cases or financial impact.

RECENT AI CATALYSTS & NEWS
BUSINESS IMPACT - QUALITATIVE MATERIALITY

7/10 qualitative impact   material  medium-term · mixed evidence

Where AI matters: clinical workflow, revenue cycle, staffing and throughput

HCA is deploying AI across high-friction hospital workflows including ambient physician documentation, nurse handoffs, case management, revenue cycle, supply chain and staffing, where even modest productivity or length-of-stay gains can matter at scale. The upside is credible because it targets labor intensity and throughput, but still not transformational because management has not isolated AI-driven savings or shown that AI changes HCA's core care model.

Caveats: AI contribution to the $400 million resiliency target is not separately quantified; Clinical AI adoption may be slower due to liability, workflow integration and physician trust; Benefits may accrue to vendors or payers as much as HCA if pricing and reimbursement adjust; Automation in case management or revenue cycle could face payer pushback or regulatory scrutiny

AI DISRUPTION / CANNIBALIZATION RISK  tailwind · 2/10

AI does not commoditize HCA's core business of operating hospitals and delivering regulated, facility-based acute care; physical capacity, payer contracts, licenses, clinician networks and local market density remain durable. Some low-acuity care may shift to virtual or automated triage, but that is more a channel and cost-management pressure than a direct automation of HCA's revenue model.

OPTIONS / MARKET STRUCTURE

option liquidity: good

ATM IV
—
TYPICAL BID-ASK
—
OPEN INTEREST
—

proxy inputs — dollar-ADV $442M · beta 1.19 · px $367.35

source: proxy (no options chain on FMP)
FMP /stable/ exposes no options-chain endpoint on this key, so ATM IV, bid-ask spread and open interest are unavailable. Liquidity below is a PROXY from dollar-ADV, beta and price level (a stand-in for option depth), not measured option-market data.

CONFIRMATION — INSIDERS · 13F · LANGUAGE
Mixed — insiders selling, institutions adding, management language 3/10 hedged.
INSIDERS selling 12 open-market sell(s) vs 0 buy(s) — net distribution
INSTITUTIONS (13F) adding as of 2026-03-31: 150 new / 140 closed positions; 638 increased / 557 reduced; institutional ownership -2.54pp; +13 net 13F holders
MGMT LANGUAGE 3/10 hedged AI was barely discussed; language signals activity and rollout, but lacks quantified impact, named initiatives, or firm business outcomes.
commit “They progressed during the quarter with rollout of some key initiatives to more facilities.”
hedge “I remain excited about our digital transformation program and AI agenda.”
hedge “rollout of some key initiatives to more facilities.”
VERBATIM AI QUOTES
“I remain excited about our digital transformation program and AI agenda. They progressed during the quarter with rollout of some key initiatives to more facilities.”
— Samuel Hazen, Q1 FY2026
“I will tell you that our artificial intelligence agenda is getting implemented. We have productivity with our physicians, with our ambient listening capabilities and the documentation associated with that.”
— Samuel Hazen, Q1 FY2026
“We're rolling out our nurse handoff program, as I mentioned. We've got new initiatives that are rolling out to more facilities. That's got more patient safety and nurse engagement, some productivity to it.”
— Samuel Hazen, Q1 FY2026
“We're really excited about what the artificial intelligence program can do to complement our caregivers in our company and help us provide better care, do it more cost effectively and run the business better.”
— Samuel Hazen, Q1 FY2026
“We're seeing it in case management. We had good outcomes with case management, as we talked about with average length of stay.”
— Samuel Hazen, Q1 FY2026
“These results allowed us to invest significantly in our networks, our people, and our AI and tech agenda.”
— Samuel Hazen, Q4 FY2025
“We are leveraging three primary capabilities in driving our financial program. First, internal and external benchmarking and advanced analytics. Second, digital transformation with AI and automation. And third, expanding and leveraging our shared service platforms.”
— Mike Hart, Q4 FY2025
“Lastly, we plan to continue investing in our technology and digital innovation strategy, which we expect will deliver long-term value and help position the company for future.”
— Mike Hart, Q4 FY2025
“Now we have tools, as Mike alluded to, that are in front of us as opportunities to create even more consistency, efficiencies, transparency in the company's overall cost.”
— Samuel Hazen, Q4 FY2025
“And as we get more capable at using these tools, it's gonna help us find even more opportunities.”
— Samuel Hazen, Q4 FY2025
“And so we're implementing as we speak in our revenue cycle, in supply chain, and other areas to move, through some transitions into artificial intelligence supporting better functioning, more efficiencies, better interaction with payers and vendors and so forth.”
— Samuel Hazen, Q4 FY2025
“And so, again, a lot of good ideas and a lot of tools that we think AI can bring to the operations of our hospital.”
— Samuel Hazen, Q4 FY2025
“We believe with HCA's proprietary database that we have a wonderful opportunity to use those patterns to help our physicians in the moment make better decisions more informed decisions potentially for their patients in a way that will improve care.”
— Samuel Hazen, Q4 FY2025
“The opportunity to support our nurses with tools that make it easier for them to do shift change, to have a safety net underneath their day-to-day activities so they can make the patient environment safer and more efficient is in front of us.”
— Samuel Hazen, Q4 FY2025
“We are all in on the possibilities with artificial intelligence, merging with what I call the human intelligence that exists within our facilities.”
— Samuel Hazen, Q4 FY2025
ANALYST QUESTIONS ON AI
Q (Q1 FY2026, Albert Rice): Could I just -- as a follow-up, your $400 million resiliency program, I know you've got a lot of AI initiatives and -- but some of that is other stuff. Can you just sort of update us on where you're at with the AI initiatives? And is that $400 million a pretty firm number? Is there a range around that as to what you might ultimately realize this year?
A: I will tell you that our artificial intelligence agenda is getting implemented. We have productivity with our physicians, with our ambient listening capabilities and the documentation associated with that. We're rolling out our nurse handoff program, as I mentioned. We've got new initiatives that are rolling out to more facilities. That's got more patient safety and nurse engagement, some productivity to it. We're really excited about what the artificial intelligence program can do to complement our caregivers in our company and help us provide better care, do it more cost effectively and run the business better. We're seeing it in case management. We had good outcomes with case management, as we talked about with average length of stay.
Q (Q4 FY2025, Anna): To ask the $400 million of resiliency benefit in '26 is impressive. Can you talk about how much of that comes from ramping AI initiatives and how we should think about further resiliency opportunities beyond 2026?
A: I think that the way to think about our resiliency program is that it's a multiyear program. The $400 million came from our assessment of implementation status of the long list of opportunities that we're working on. And based on that assessment of our implementation status, it gave us confidence to include $400 million of savings in '26 versus '25 in our overall guidance.
Q (Q4 FY2025, Joshua Raskin): I know that came up a little bit, but can you speak to your technology agenda and where you think the greatest opportunities are for HCA and specifically interested in areas where you think AI can help already looking at both the administrative cost, but also as well as the revenue enhancement opportunities.
A: The first domain is administrative, and you alluded to that. That is an area that's focused on revenue cycle, human resources, IT supply chain in many instances, and a few other areas. That we think we can accelerate into because we're more consolidated in our operations. And so we're implementing as we speak in our revenue cycle, in supply chain, and other areas to move, through some transitions into artificial intelligence supporting better functioning, more efficiencies, better interaction with payers and vendors and so forth. And we should start to see some value, and that's part of what Mike alluded to again in our resiliency agenda in 2026.